The pharmaceutical and biotechnology firm, Wuxi AppTec (02359), has executed a significant share repurchase. According to a company filing, on June 8, 2026, it deployed HK$110 million to buy back 912,600 of its own shares.
The transaction was carried out at a price range of HK$119.2 to HK$123.8 per share.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.